Potentiation of C1 esterase inhibitor by StcE, a metalloprotease secreted by Escherichia coli O157:H7

The complement system is an essential component of host defense against pathogens. Previous research in our laboratory identified StcE, a metalloprotease secreted by Escherichia coli O157:H7 that cleaves the serpin C1 esterase inhibitor (C1-INH), a major regulator of the classical complement cascade...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Journal of experimental medicine 2004-04, Vol.199 (8), p.1077-1087
Hauptverfasser: Lathem, Wyndham W, Bergsbaken, Tessa, Welch, Rodney A
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1087
container_issue 8
container_start_page 1077
container_title The Journal of experimental medicine
container_volume 199
creator Lathem, Wyndham W
Bergsbaken, Tessa
Welch, Rodney A
description The complement system is an essential component of host defense against pathogens. Previous research in our laboratory identified StcE, a metalloprotease secreted by Escherichia coli O157:H7 that cleaves the serpin C1 esterase inhibitor (C1-INH), a major regulator of the classical complement cascade. Analyses of StcE-treated C1-INH activity revealed that surprisingly, StcE enhanced the ability of C1-INH to inhibit the classical complement-mediated lysis of sheep erythrocytes. StcE directly interacts with both cells and C1-INH, thereby binding C1-INH to the cell surface. This suggests that the augmented activity of StcE-treated C1-INH is due to the increased concentration of C1-INH at the sites of potential lytic complex formation. Indeed, removal of StcE abolishes the ability of C1-INH to bind erythrocyte surfaces, whereas the proteolysis of C1-INH is unnecessary to potentiate its inhibitory activity. Physical analyses showed that StcE interacts with C1-INH within its aminoterminal domain, allowing the unaffected serpin domain to interact with its targets. In addition, StcE-treated C1-INH provides significantly increased serum resistance to E. coli K-12 over native C1-INH. These data suggest that by recruiting C1-INH to cell surfaces, StcE may protect both E. coli O157:H7 and the host cells to which the bacterium adheres from complement-mediated lysis and potentially damaging inflammatory events.
doi_str_mv 10.1084/jem.20030255
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2211892</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>17703612</sourcerecordid><originalsourceid>FETCH-LOGICAL-c411t-6797ec92a6daf543003085701b2ae24e6b1e0a9b7e806cb50500fb3fac7770c3</originalsourceid><addsrcrecordid>eNpVkUFv2zAMhYViQ5ulve086LRT3ZGyZdk7DBiCdClQoAXauyArdKPCtjJJGZB_XxtJ1_bEAz8-8vEx9hXhCqEqfjxTfyUAchBSnrAZygKyWubVJzYDECJDAHXGvsT4DIBFIctTdoYS6lLm5YzRvU80JGeS8wP3LV8gp5gomEjcDRvXuOQDb_b8IdnlJTe8p2S6zm_DODhBkWygROuJWUa7oeDsxhlufef4HUr1c6XO2efWdJEujnXOHq-Xj4tVdnv352bx-zazBWLKSlUrsrUw5dq0ssgnV5VUgI0wJAoqGyQwdaOogtI2EiRA2-StsUopsPmc_TrIbndNT2s7Ggum09vgehP22hunP3YGt9FP_p8WArGqxSjw_SgQ_N_d-Afdu2ip68xAfhc1jmvyEifw8gDa4GMM1P5fgqCnWPQYi36NZcS_vT_sDT7mkL8ANLqI_g</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17703612</pqid></control><display><type>article</type><title>Potentiation of C1 esterase inhibitor by StcE, a metalloprotease secreted by Escherichia coli O157:H7</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Lathem, Wyndham W ; Bergsbaken, Tessa ; Welch, Rodney A</creator><creatorcontrib>Lathem, Wyndham W ; Bergsbaken, Tessa ; Welch, Rodney A</creatorcontrib><description>The complement system is an essential component of host defense against pathogens. Previous research in our laboratory identified StcE, a metalloprotease secreted by Escherichia coli O157:H7 that cleaves the serpin C1 esterase inhibitor (C1-INH), a major regulator of the classical complement cascade. Analyses of StcE-treated C1-INH activity revealed that surprisingly, StcE enhanced the ability of C1-INH to inhibit the classical complement-mediated lysis of sheep erythrocytes. StcE directly interacts with both cells and C1-INH, thereby binding C1-INH to the cell surface. This suggests that the augmented activity of StcE-treated C1-INH is due to the increased concentration of C1-INH at the sites of potential lytic complex formation. Indeed, removal of StcE abolishes the ability of C1-INH to bind erythrocyte surfaces, whereas the proteolysis of C1-INH is unnecessary to potentiate its inhibitory activity. Physical analyses showed that StcE interacts with C1-INH within its aminoterminal domain, allowing the unaffected serpin domain to interact with its targets. In addition, StcE-treated C1-INH provides significantly increased serum resistance to E. coli K-12 over native C1-INH. These data suggest that by recruiting C1-INH to cell surfaces, StcE may protect both E. coli O157:H7 and the host cells to which the bacterium adheres from complement-mediated lysis and potentially damaging inflammatory events.</description><identifier>ISSN: 0022-1007</identifier><identifier>EISSN: 1540-9538</identifier><identifier>DOI: 10.1084/jem.20030255</identifier><identifier>PMID: 15096536</identifier><language>eng</language><publisher>United States: The Rockefeller University Press</publisher><subject>Animals ; Complement C1 Inactivator Proteins - administration &amp; dosage ; Complement C1 Inactivator Proteins - metabolism ; Complement Pathway, Classical - drug effects ; COS Cells ; Drug Synergism ; Erythrocytes - drug effects ; Erythrocytes - metabolism ; Escherichia coli ; Escherichia coli O157 - enzymology ; Escherichia coli Proteins - administration &amp; dosage ; Hemolysis - drug effects ; Humans ; Immunity, Innate - drug effects ; In Vitro Techniques ; Metalloendopeptidases - administration &amp; dosage ; Models, Biological ; Sheep</subject><ispartof>The Journal of experimental medicine, 2004-04, Vol.199 (8), p.1077-1087</ispartof><rights>Copyright © 2004, The Rockefeller University Press</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c411t-6797ec92a6daf543003085701b2ae24e6b1e0a9b7e806cb50500fb3fac7770c3</citedby><cites>FETCH-LOGICAL-c411t-6797ec92a6daf543003085701b2ae24e6b1e0a9b7e806cb50500fb3fac7770c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,777,781,882,27905,27906</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15096536$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lathem, Wyndham W</creatorcontrib><creatorcontrib>Bergsbaken, Tessa</creatorcontrib><creatorcontrib>Welch, Rodney A</creatorcontrib><title>Potentiation of C1 esterase inhibitor by StcE, a metalloprotease secreted by Escherichia coli O157:H7</title><title>The Journal of experimental medicine</title><addtitle>J Exp Med</addtitle><description>The complement system is an essential component of host defense against pathogens. Previous research in our laboratory identified StcE, a metalloprotease secreted by Escherichia coli O157:H7 that cleaves the serpin C1 esterase inhibitor (C1-INH), a major regulator of the classical complement cascade. Analyses of StcE-treated C1-INH activity revealed that surprisingly, StcE enhanced the ability of C1-INH to inhibit the classical complement-mediated lysis of sheep erythrocytes. StcE directly interacts with both cells and C1-INH, thereby binding C1-INH to the cell surface. This suggests that the augmented activity of StcE-treated C1-INH is due to the increased concentration of C1-INH at the sites of potential lytic complex formation. Indeed, removal of StcE abolishes the ability of C1-INH to bind erythrocyte surfaces, whereas the proteolysis of C1-INH is unnecessary to potentiate its inhibitory activity. Physical analyses showed that StcE interacts with C1-INH within its aminoterminal domain, allowing the unaffected serpin domain to interact with its targets. In addition, StcE-treated C1-INH provides significantly increased serum resistance to E. coli K-12 over native C1-INH. These data suggest that by recruiting C1-INH to cell surfaces, StcE may protect both E. coli O157:H7 and the host cells to which the bacterium adheres from complement-mediated lysis and potentially damaging inflammatory events.</description><subject>Animals</subject><subject>Complement C1 Inactivator Proteins - administration &amp; dosage</subject><subject>Complement C1 Inactivator Proteins - metabolism</subject><subject>Complement Pathway, Classical - drug effects</subject><subject>COS Cells</subject><subject>Drug Synergism</subject><subject>Erythrocytes - drug effects</subject><subject>Erythrocytes - metabolism</subject><subject>Escherichia coli</subject><subject>Escherichia coli O157 - enzymology</subject><subject>Escherichia coli Proteins - administration &amp; dosage</subject><subject>Hemolysis - drug effects</subject><subject>Humans</subject><subject>Immunity, Innate - drug effects</subject><subject>In Vitro Techniques</subject><subject>Metalloendopeptidases - administration &amp; dosage</subject><subject>Models, Biological</subject><subject>Sheep</subject><issn>0022-1007</issn><issn>1540-9538</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVkUFv2zAMhYViQ5ulve086LRT3ZGyZdk7DBiCdClQoAXauyArdKPCtjJJGZB_XxtJ1_bEAz8-8vEx9hXhCqEqfjxTfyUAchBSnrAZygKyWubVJzYDECJDAHXGvsT4DIBFIctTdoYS6lLm5YzRvU80JGeS8wP3LV8gp5gomEjcDRvXuOQDb_b8IdnlJTe8p2S6zm_DODhBkWygROuJWUa7oeDsxhlufef4HUr1c6XO2efWdJEujnXOHq-Xj4tVdnv352bx-zazBWLKSlUrsrUw5dq0ssgnV5VUgI0wJAoqGyQwdaOogtI2EiRA2-StsUopsPmc_TrIbndNT2s7Ggum09vgehP22hunP3YGt9FP_p8WArGqxSjw_SgQ_N_d-Afdu2ip68xAfhc1jmvyEifw8gDa4GMM1P5fgqCnWPQYi36NZcS_vT_sDT7mkL8ANLqI_g</recordid><startdate>20040419</startdate><enddate>20040419</enddate><creator>Lathem, Wyndham W</creator><creator>Bergsbaken, Tessa</creator><creator>Welch, Rodney A</creator><general>The Rockefeller University Press</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope><scope>5PM</scope></search><sort><creationdate>20040419</creationdate><title>Potentiation of C1 esterase inhibitor by StcE, a metalloprotease secreted by Escherichia coli O157:H7</title><author>Lathem, Wyndham W ; Bergsbaken, Tessa ; Welch, Rodney A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c411t-6797ec92a6daf543003085701b2ae24e6b1e0a9b7e806cb50500fb3fac7770c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Animals</topic><topic>Complement C1 Inactivator Proteins - administration &amp; dosage</topic><topic>Complement C1 Inactivator Proteins - metabolism</topic><topic>Complement Pathway, Classical - drug effects</topic><topic>COS Cells</topic><topic>Drug Synergism</topic><topic>Erythrocytes - drug effects</topic><topic>Erythrocytes - metabolism</topic><topic>Escherichia coli</topic><topic>Escherichia coli O157 - enzymology</topic><topic>Escherichia coli Proteins - administration &amp; dosage</topic><topic>Hemolysis - drug effects</topic><topic>Humans</topic><topic>Immunity, Innate - drug effects</topic><topic>In Vitro Techniques</topic><topic>Metalloendopeptidases - administration &amp; dosage</topic><topic>Models, Biological</topic><topic>Sheep</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lathem, Wyndham W</creatorcontrib><creatorcontrib>Bergsbaken, Tessa</creatorcontrib><creatorcontrib>Welch, Rodney A</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>The Journal of experimental medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lathem, Wyndham W</au><au>Bergsbaken, Tessa</au><au>Welch, Rodney A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Potentiation of C1 esterase inhibitor by StcE, a metalloprotease secreted by Escherichia coli O157:H7</atitle><jtitle>The Journal of experimental medicine</jtitle><addtitle>J Exp Med</addtitle><date>2004-04-19</date><risdate>2004</risdate><volume>199</volume><issue>8</issue><spage>1077</spage><epage>1087</epage><pages>1077-1087</pages><issn>0022-1007</issn><eissn>1540-9538</eissn><abstract>The complement system is an essential component of host defense against pathogens. Previous research in our laboratory identified StcE, a metalloprotease secreted by Escherichia coli O157:H7 that cleaves the serpin C1 esterase inhibitor (C1-INH), a major regulator of the classical complement cascade. Analyses of StcE-treated C1-INH activity revealed that surprisingly, StcE enhanced the ability of C1-INH to inhibit the classical complement-mediated lysis of sheep erythrocytes. StcE directly interacts with both cells and C1-INH, thereby binding C1-INH to the cell surface. This suggests that the augmented activity of StcE-treated C1-INH is due to the increased concentration of C1-INH at the sites of potential lytic complex formation. Indeed, removal of StcE abolishes the ability of C1-INH to bind erythrocyte surfaces, whereas the proteolysis of C1-INH is unnecessary to potentiate its inhibitory activity. Physical analyses showed that StcE interacts with C1-INH within its aminoterminal domain, allowing the unaffected serpin domain to interact with its targets. In addition, StcE-treated C1-INH provides significantly increased serum resistance to E. coli K-12 over native C1-INH. These data suggest that by recruiting C1-INH to cell surfaces, StcE may protect both E. coli O157:H7 and the host cells to which the bacterium adheres from complement-mediated lysis and potentially damaging inflammatory events.</abstract><cop>United States</cop><pub>The Rockefeller University Press</pub><pmid>15096536</pmid><doi>10.1084/jem.20030255</doi><tpages>11</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0022-1007
ispartof The Journal of experimental medicine, 2004-04, Vol.199 (8), p.1077-1087
issn 0022-1007
1540-9538
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2211892
source MEDLINE; EZB-FREE-00999 freely available EZB journals
subjects Animals
Complement C1 Inactivator Proteins - administration & dosage
Complement C1 Inactivator Proteins - metabolism
Complement Pathway, Classical - drug effects
COS Cells
Drug Synergism
Erythrocytes - drug effects
Erythrocytes - metabolism
Escherichia coli
Escherichia coli O157 - enzymology
Escherichia coli Proteins - administration & dosage
Hemolysis - drug effects
Humans
Immunity, Innate - drug effects
In Vitro Techniques
Metalloendopeptidases - administration & dosage
Models, Biological
Sheep
title Potentiation of C1 esterase inhibitor by StcE, a metalloprotease secreted by Escherichia coli O157:H7
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T19%3A24%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Potentiation%20of%20C1%20esterase%20inhibitor%20by%20StcE,%20a%20metalloprotease%20secreted%20by%20Escherichia%20coli%20O157:H7&rft.jtitle=The%20Journal%20of%20experimental%20medicine&rft.au=Lathem,%20Wyndham%20W&rft.date=2004-04-19&rft.volume=199&rft.issue=8&rft.spage=1077&rft.epage=1087&rft.pages=1077-1087&rft.issn=0022-1007&rft.eissn=1540-9538&rft_id=info:doi/10.1084/jem.20030255&rft_dat=%3Cproquest_pubme%3E17703612%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=17703612&rft_id=info:pmid/15096536&rfr_iscdi=true